• Синдром бронхиальной обструкции у детей (визинг, свистящее дыхание). Клиническая установка, основанная на доказательствахГосударственный экспертный центр Министерства здравоохранения Украины
ru К содержанию Полный текст статьи

Синдром бронхиальной обструкции у детей (визинг, свистящее дыхание). Клиническая установка, основанная на доказательствахГосударственный экспертный центр Министерства здравоохранения Украины

ОС «Украинская Академия Педиатрических специальностей»
Медицинская сеть «Добробут»
Коллектив авторов:

А.А. Рыков, Е.В. Фещенко, С.М. Горолевич, Н.А. Москвина, Е.М. Лищишина

ЛИТЕРАТУРА

1. Martinez FD, Wright AL, Taussig LM et al. (1995). Asthma and wheezing in the first six years of life. N Engl J Med. 332: 133—138.

2. Bisgaard H, Szefler S. (2007). Prevalence of asthma-like symptoms in young children. Pediatr Pulmonol. 42: 723—728.

3. Stevens CA, Turner D, Kuehni CE et al. (2003). The economic impact of preschool asthma and wheeze. Eur Respir J. 21: 1000—1006.

4. Kurukulaaratchy RJ, Fenn MH, Waterhouse LM et al. (2003). Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy.33: 573—578.

5. Lau S, Illi S, Sommerfeld C et al. (2003). Transient early wheeze is not associated with impaired lung function in 7- year-old children. Eur Respir J.21: 834—841.

6. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. www.ginasthma.org/Guidelineitem.asp??l152&l251&intId560 Date last updated: 2007. Date last accessed: July 27, 2008.

7. British Thoracic Society, Scottish Intercollegiate Guidelines Network.: British guideline on the management of asthma. (2003). Thorax. 58(1): i1-i94.

8. National Heart, Lung and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, National Heart, Lung and Blood Institute, 2007.

9. Kuehni CE. (2005). Phenotype specific treatment of obstructive airways disease in infancy and childhood: new recommendations of the Swiss Paediatric Pulmonology Group. Swiss Med Wkly.135: 95—100.

10. Monge RM, Montaner AE, Benitez MF et al. (2006). Consensus statement on the management of paediatric asthma. Allergol Immunopathol (Madr). 34: 88—101.

11. Bush A. (2006). Coughs and wheezes spread diseases: but what about the environment? Thorax. 61: 367—368.

12. Bacharier LB, Boner A, Carlsen KH et al. (2008). Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 63: 5—34.

13. Atkins D, Best D, Briss PA et al. (2004). Grading quality of evidence and strength of recommendations. BMJ. 328: 1490—1494.

14. Saglani S, Malmstrom K, Pelkonen AS et al. (2005). Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med. 171: 722—727.

15. Elphick HE, Sherlock P, Foxall G et al. (2001). Survey of respiratory sounds in infants. Arch Dis Child; 84: 35—39.

16. Michel G, Silverman M, Strippoli MP et al. (2006). Parental understanding of wheeze and its impact on asthma prevalence estimates. Eur Respir J. 28: 1124—1130.

17. Elphick HE, Ritson S, Rodgers H, Everard ML. (2000). When a ''wheeze'' is not a wheeze: acoustic analysis of breath sounds in infants. Eur Respir J. 16: 593—597.

18. Cane RS, Ranganathan SC, McKenzie SA. (2000). What do parents of wheezy children understand by ''wheeze''? Arch Dis Child. 82: 327—332.

19. Cane RS, McKenzie SA. (2001). Parents' interpretations of children's respiratory symptoms on video. Arch Dis Child. 84: 31—34.

20. Levy ML, Godfrey S, Irving CS et al. (2004). Wheeze detection: recordings vs assessment of physician and parent. J Asthma. 41: 845—853.

21. Shields MD, Bush A, Everard ML, McKenzie SA, Primhak R. (2008). Recommendations for the assessment and management of cough in children. Thorax. 63;3: iii1-iii15.

22. Silverman M. (2002). Wheezing disorders in infants and young children. In: Silverman M, ed. Childhood Asthma and Other Wheezing Disorders. London, Arnold: 307—332.

23. Martinez FD, Godfrey S. (2003). Wheezing Disorders in the Preschool Child: Epidemiology, Diagnosis and Treatment. London: Martin Dunitz.

24. Martinez FD. (2007). Genes, environments, development and asthma: a reappraisal. Eur Respir J. 29: 179—184.

25. Wenzel SE. (2006). Asthma: defining of the persistent adult phenotypes. Lancet. 368: 804—813.

26. Doull IJM, Lampe FC, Smith S et al. (1997). Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ. 315: 858—862.

27. Mckean MC, Hewitt C, Lambert PC et al. (2003). An adult model of exclusive viral wheeze: inflammation in the upper and lower respiratory tracts. Clin Exp Allergy. 33: 912—920.

28. Papadopoulos NG, Kalobatsou A. (2007). Respiratory viruses in childhood asthma. Curr Opin Allergy Clin Immunol. 7: 91—95.

29. Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM et al. (2005). Teenage asthma after severe early childhood wheezing: an 11-year prospective followup. Pediatr Pulmonol. 40: 316—323.

30. Bradley JP, Bacharier LB, Bonfiglio J et al. (2005). Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 115: e7-e14.

31. Horn SD, Smout RJ. (2003). Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr. 143: 133—141.

32. Lannero E, Wickman M, Pershagen G, Nordvall L. (2006). Maternal smoking during pregnancy increases the risk of recurrent wheezing during the first years of life (BAMSE). Respir Res. 7: 3.

33. Mertsola J, Ziegler T, Ruuskanen O et al. (1991). Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 66: 124—129.

34. Rylander E, Eriksson M, Freyschuss U. (1988). Risk factors for occasional and recurrent wheezing after RSV infection in infancy. Acta Paediatr Scand. 77: 711—715.

35. Simoes EA, King SJ, Lehr MV, Groothuis JR. (1993). Preterm twins and triplets. A high-risk group for severe respiratory syncytial virus infection. Am J Dis Child. 147: 303—306.

36. Bont L, van Aalderen WMC, Kimpen JLL. (2000). Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr Respir Rev. 1: 221—227.

37. Stein RT, Sherill D, Morgan WJ et al. (1999). Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 354: 541—545.

38. Lemanske RF Jr, Jackson DJ, Gangnon RE et al. (2005). Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 116: 571—577.

39. Castro-Rodri’guez JA, Holberg CJ, Wright AL, Martinez FD. (2000). A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 162: 1403—1406.

40. Teper AM, Kofman CD, Szulman GA et al. (2005). Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med. 171: 587—590.

41. Guilbert TW, Morgan WJ, Zeiger RS et al. (2006). Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 354: 1985—1997.

42. Taussig LM, Wright AL, Holberg CJ et al. (2003). Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol. 111: 661—675.

43. Hess J, de Jongste JC. (2004). Epidemiological aspects of paediatric asthma. Clin Exp Allergy. 34: 680—685.

44. Goksor E1, Amark M, Alm B, Gustafsson PM, Wennergren G. (2006). Asthma symptoms in early childhood — what happens then? Acta Paediatr. 95: 471—478.

45. Wennergren G, Hansson S, Engstrom I et al. (1992). Characteristics and prognosis of hospital-treated obstructive bronchitis in children aged less than two years. Acta Paediatr. 81: 40—45.

46. Piippo-Savolainen E, Remes S, Kannisto S et al. (2004). Asthma and lung function 20 years after wheezing in infancy: results from a prospective followup study. Arch Pediatr Adolesc Med. 158: 1070—1076.

47. Lowe L, Murray CS, Martin L et al. (2004). Reported versus confirmed wheeze and lung function in early life. Arch Dis Child. 89: 540—543.

48. Elphick HE, Lancaster GA, Solis A et al. (2004). Validity and reliability of acoustic analysis of respiratory sounds in infants.Arch Dis Child. 8

49. Saglani S, McKenzie SA, Bush A, Payne DN. (2005). A video questionnaire identifies upper airway abnormalities in preschool children with reported wheeze. Arch Dis Child. 90: 961—964.

50. Hofhuis W, van der Wiel EC, Tiddens HAWM et al. (2003). Bronchodilation in infants with malacia or recurrent wheeze. Arch Dis Child. 88: 246—249.

51. Saglani S, Nicholson AG, Scallan M et al. (2006). Investigation of young children with severe recurrent wheeze: any clinical benefit? Eur Respir J. 27: 29—35.

52. Saito J, Harris WT, Gelfond J et al. (2006). Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatr Pulmonol. 41: 709—719.

53. Chan EY, Dundas I, Bridge PD et al. (2005). Skin-prick testing as a diagnostic aid for childhood asthma. Pediatr Pulmonol. 39: 558—562.

54. Eysink PE, ter Riet G, Aalberse RC et al. (2005). Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice. Br J Gen Pract. 55: 125—131.

55. Nickel R, Kulig M, Forster J et al. (1997). Sensitization to hen's egg at the age of twelve months is predictive for allergic sensitization to common indoor and outdoor allergens at the age of three years. J Allergy Clin Immunol. 99: 613—617.

56. Rusconi F, Patria MF, Cislaghi GU et al. (2001). Total serum IgE and outcome in infants with recurrent wheezing. Arch Dis Child. 85: 23—25.

57. Koller DY, Wojnarowski C, Herkner KR et al. (1997). High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol. 99: 752—756.

58. Hederos CA, Janson S, Andersson H, Hedlin G. (2004). Chest Xray investigation in newly discovered asthma. Pediatr Allergy Immunol. 15: 163—165.

59. Sheikh S, Stephen T, Howell L, Eid N. (1999). Gastroesophageal reflux in infants with wheezing. Pediatr Pulmonol. 28: 181—186.

60. Neve V, Edme JL, Devos P et al. (2006). Spirometry in 3—5-year-old children with asthma. Pediatr Pulmonol. 41: 735—743.

61. Young S, Arnott J, O'Keeffe PT et al. (2000). The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J. 15: 151—157.

62. de Gooijer A, Brand PLP, Gerritsen J et al. (1993). Changes in respiratory symptoms and airway reactivity after 27 years in a population-based sample of school children. Eur Respir J. 6: 848—854.

63. Roorda RJ, Gerritsen J, van Aalderen WMC et al. (1994). Followup of asthma from childhood to adulthood: influence of potential childhood risk factors on the outcome of pulmonary function and bronchial responsiveness in adulthood. J Allergy Clin Immunol. 93: 575—584.

64. Sears MR, Greene JM, Willan AR et al. (2003). A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med. 349: 1414—1422.

65. Stern DA, Morgan WJ, Wright AL et al. (2007). Poor airway function in early infancy and lung function 9: 1059—1063.

66. Turner SW, Palmer LJ, Rye PJ et al. (2004). The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med. 169: 921—927.

67. Kim DK, Choi SH, Yu J et al. (2007). Bronchial responsiveness to methacholine and adenosine 59-monophosphate in atopic and non-atopic preschool children with recurrent wheezing. Clin Exp Allergy. 37: 15—21.

68. Nielsen KG, Bisgaard H. (2001). Discriminative capacity of bronchodilator response measured with three different

lung function techniques in asthmatic and healthy children aged 2 to 5 years. Am J Respir Crit Care Med. 164: 554—559.

69. Dundas I, Chan EY, Bridge PD, McKenzie SA. (2005). Diagnostic accuracy of bronchodilator responsiveness in wheezy

children. Thorax. 60: 13—16.

70. Gabriele C, Nieuwhof EM, van der Wiel EC et al. (2006). Exhaled nitric oxide differentiates airway diseases in the first two

years of life. Pediatr Res. 60: 461—465.

71. Baraldi E, Dario C, Ongaro R et al. (1999). Exhaled nitric oxide concentrations during treatment of wheezing exacerbation

in infants and young children. Am J Respir Crit Care Med. 159: 1284—1288.

72. Moeller A, Franklin P, Hall GL et al. (2004). Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrent

wheezy infants. Pediatr Pulmonol. 38: 250—255.

73. Straub DA, Moeller A, Minocchieri S et al. (2005). The effect of montelukast on lung function and exhaled nitric oxide in

infants with early childhood asthma. Eur Respir J. 25: 289—294.

74. Straub DA, Minocchieri S, Moeller A et al. (2005). The effect of montelukast on exhaled nitric oxide and lung function in

asthmatic children 2 to 5 years old. Chest. 127: 509—514.

75. Frey U, Kuehni C, Roiha H et al. (2004). Maternal atopic disease modifies effects of prenatal risk factors on exhaled nitric

oxide in infants. Am J Respir Crit Care Med. 170: 260—265.

76. Buchvald F, Baraldi E, Carraro S et al. (2005). Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years.

J Allergy Clin Immunol. 115: 1130—1136.

77. Wildhaber JH, Sennhauser FH, Brand PLP. (2006). Asthma in school@aged children and adolescents. In: Frey U, Gerritsen

J, eds. Respiratory Diseases in Infants and Childrend. Eur Respir Mon. 11: 191—216.

78. Saglani S, Payne DN, Zhu J et al. (2007). Early detection of airway wall remodelling and eosinophilic inflammation in pre@

school wheezers. Am J Respir Crit Care Med. 176: 858—864.

79. Strachan DP, Cook DG. (1997). Parental smoking and lower respiratory illness in infancy and early childhood. Thorax. 52:

905—914.

80. Murray CS, Poletti G, Kebadze T et al. (2006). Study of modifiable risk factors for asthma exacerbations: virus infection

and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 61: 376—382.

81. Torrent M, Sunyer J, Garcia R et al. (2007). Early@life allergen exposure and atopy, asthma, and wheeze up to 6 years of

age. Am J Respir Crit Care Med. 176: 446—453.

82. Lowe LA, Woodcock A, Murray CS et al. (2004). Lung function at age 3 years: effect of pet ownership and exposure to

indoor allergens. Arch Pediatr Adolesc Med. 158: 996—1001.

83. Illi S, von Mutius E, Lau S et al. (2006). Perennial allergen sensitisation early in life and chronic asthma in children: a birth

cohort study. Lancet. 368: 763—770.

84. Peroni DG, Piacentini GL, Costella S et al. (2002). Mite avoidance can reduce air trapping and airway inflammation in aller@

gic asthmatic children. Clin Exp Allergy. 32: 850—855.

85. Custovic A, Wijk RG. (2005). The effectiveness of measures to change the indoor environment in the treatment of allergic

rhinitis and asthma: ARIA update (in collaboration with GA2LEN). Allergy. 60: 1112—1115.

86. Morgan WJ, Crain EF, Gruchalla RS et al. (2004). Results of a home@based environmental intervention among urban chil@

dren with asthma. N Engl J Med. 351: 1068—1080.

87. Gore RB, Custovic A. (2002). Is allergen avoidance effective? Clin Exp Allergy. 32: 662—666.

88. Mesters I, Pieterse M, Meertens R. (1991). Pediatric asthma, a qualitative and quantitative approach to needs assess@

ment. Patient Educ Couns. 17: 23—34.

89. Wolf FM, Guevara JP, Grum CM et al. (2003). Educational interventions for asthma in children. Cochrane Database Syst

Rev. Issue 4: CD000326.

90. Wilson SR, Latini D, Starr NJ et al. (1996). Education of parents of infants and very young children with asthma: a devel@

opmental evaluation of the Wee Wheezers program. J Asthma. 33: 239—254.

91. Brown JV, Bakeman R, Celano MP et al. (2002). Home@based asthma education of young low@income children and their

families. J Pediatr Psychol. 27: 677—688.

92. Mesters I, Meertens R, Kok G, Parcel GS. (1994). Effectiveness of a multidisciplinary education protocol in children with

asthma (0—4 years) in primary health care. J Asthma. 31: 347—359.

93. Stevens CA, Wesseldine LJ, Couriel JM et al. (2002). Parental education and guided self@management of asthma and

wheezing in the preschool child: a randomised controlled trial. Thorax. 57: 39—44.

94. Holzheimer L, Mohay H, Masters IB. (1998). Educating young children about asthma: comparing the effectiveness of a

developmentally appropriate asthma education video tape and picture book. Child Care Health Dev. 24: 85—99.

95. Holmgren D, Bjure J, Engstrom I et al. (1992). Transcutaneous blood gas monitoring during salbutamol inhalations in

young children with acute asthmatic symptoms. Pediatr Pulmonol. 14: 75—79.

96. Kraemer R, Frey U, Sommer CW, Russi E. (1991). Short@term effect of albuterol, delivered via a new auxiliary device, in

wheezy infants. Am Rev Respir Dis. 144: 347—351.

97. Conner WT, Dolovich MB, Frame RA, Newhouse MT. (1989). Reliable salbutamol administration in 6@ to 36@month@old chil@

dren by means of a metered dose inhaler and Aerochamber with mask. Pediatr Pulmonol. 6: 263—267.

98. Pool JB, Greenough A, Gleeson JG, Price JF. (1988). Inhaled bronchodilator treatment via the nebuhaler in young asth@

matic patients. Arch Dis Child. 63: 288—291.

99. Nielsen KG, Bisgaard H. (2001). Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol

administered by mechanically actuated dry@powder inhaler and spacer. Am J Respir Crit Care Med. 164: 256—259.

100. Avital A, Godfrey S, Schachter J, Springer C. (1995). Protective effect of albuterol delivered via a spacer

device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children. Pediatr Pulmonol.

17: 281—284.

101. Prendiville A, Green S, Silverman M. (1987). Airway responsiveness in wheezy infants: evidence for functional beta adren@

ergic receptors. Thorax. 42: 100—104.

102. Fox GF, Marsh MJ, Milner AD. (1996). Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and

prednisolone. Eur J Pediatr; 155: 512—516.

103. Browne GJ, Penna AS, Phung X, Soo M. (1997). Randomised trial of intravenous salbutamol in early management of acute

severe asthma in children. Lancet. 349: 301—305.

104. Skoner DP, Greos LS, Kim KT et al. (2005). Evaluation of the safety and efficacy of levalbuterol in 2—5@year@old patients

with asthma. Pediatr Pulmonol. 40: 477—486.

105. Primhak RA, Smith CM, Yong SC et al. (1999). The bronchoprotective effect of inhaled salmeterol in preschool children: a

dose@ranging study. Eur Respir J. 13: 78—81.

106. Kaditis AG, Winnie G, Syrogiannopoulos GA. (2007). Antiinflammatory pharmacotherapy for wheezing in preschool chil@

dren. Pediatr Pulmonol. 42: 407—420.

107. Bisgaard H, Gillies J, Groenewald M, Maden C, an International Study Group. (1999). The effect of inhaled fluticasone pro@

pionate in the treatment of young asthmatic children. A dose comparison study. Am J Respir Crit Care Med. 160: 126—131.

108. de Blic J, Delacourt C, Le Bourgeois M et al. (1996). Efficacy of nebulized budesonide in treatment of severe infantile asth@

ma: a double@blind study. J Allergy Clin Immunol. 98: 14—20.

109. Baker JW, Mellon M, Wald J et al. (1999). A multiple@dosing, placebo@controlled study of budesonide inhalation

suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics.

103: 414—421.

110. Shapiro G, Mendelson L, Kraemer MJ et al. (1998). Efficacy and safety of budesonide inhalation suspension (Pulmicort

Respules) in young children with inhaled steroid@dependent, persistent asthma. J Allergy Clin Immunol. 102: 789—796.

111. Roorda RJ, Mezei G, Bisgaard H, Maden C. (2001). Response of preschool children with asthma symptoms to fluticasone

propionate. J Allergy Clin Immunol. 108: 540—546.

112. Hofhuis W, van der Wiel EC, Nieuwhof EM et al. (2005). Efficacy of fluticasone propionate on lung function and symptoms

in wheezy infants. Am J Respir Crit Care Med. 171: 328—333.

113. Schokker S, Kooi EM, de Vries TW et al. (2008). Inhaled corticosteroids for recurrent respiratory symptoms in preschool

children: randomized controlled trial. Pulm Pharmacol Ther. 21: 88—97.

114. Bisgaard H, Allen D, Milanowski J et al. (2004). Twelve@month safety and efficacy of inhaled fluticasone propionate in chil@

dren aged 1 to 3 years with recurrent wheezing. Pediatrics. 113: e87—e94.

115. McKean M, Ducharme F. (2000). Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database Syst Rev.

1: CD001107.

116. Wilson N, Sloper K, Silverman M. (1995). Effect of continuous treatment with topical corticosteroid on episodic viral

wheeze in preschool children. Arch Dis Child. 72: 317—320.

117. Ducharme FM, Lemire C, Nova FJ et al. (2007). Randomized controlled trial of intermittent high dose fluticasone versus

placebo in young children with viral@induced asthma. Am J Respir Crit Care Med. 175;1: A958.

118. Silverman M, Wang M, Hunter G, Taub N. (2003). Episodic viral wheeze in preschool children: effect of topical nasal cor@

ticosteroid prophylaxis. Thorax. 58: 431—434.

119. Bisgaard H, Hermansen MN, Loland L et al. (2006). Intermittent inhaled corticosteroids in infants with episodic wheezing.

N Engl J Med. 354: 1998—2005.

120. Murray CS, Woodcock A, Langley SJ et al. (2006). Secondary prevention of asthma by the use of inhaled fluticasone pro@

pionate in wheezy infants (IFWIN): double@blind, randomised, controlled study. Lancet. 368: 754—762.

121. Smith M, Iqbal S, Elliott TM et al. (2003). Corticosteroids for hospitalised children with acute asthma. Cochrane Database

Syst Rev.1: CD002886.

122. Vuillermin P, South M, Robertson C. (2006). Parent@initiated oral corticosteroid therapy for intermittent wheezing illness@

es in children. Cochrane Database Syst Rev.3: CD005311.

123. Knorr B, Franchi LM, Bisgaard H et al. (2001). Montelukast, a leukotriene receptor antagonist, for the treatment

of persistent asthma in children aged 2 to 5 years. Pediatrics. 108: e48.

124. Bisgaard H, Nielsen KG. (2000). Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool

children. Am J Respir Crit Care Med. 162: 187—190.

125. Hakim F, Vilozni D, Adler A et al. (2007). The effect of montelukast on bronchial hyperreactivity in preschool children.

Chest. 131: 180—186.

126. Szefler SJ, Baker JW, Uryniak T et al. (2007). Comparative study of budesonide inhalation suspension and montelukast

in young children with mild persistent asthma. J Allergy Clin Immunol. 120: 1043—1050.

127. Bisgaard H, Zielen S, Garcia@Garcia ML et al. (2005). Montelukast reduces asthma exacerbations in 2@ to 5@ year@old

children with intermittent asthma. Am J Respir Crit Care Med. 171: 315—322.

128. Robertson CF, Price D, Henry R et al. (2007). Short@course montelukast for intermittent asthma in children: a randomized

controlled trial. Am J Respir Crit Care Med. 175: 323—329.

129. van der Wouden JC, Tasche MJ, Bernsen RM (2003). Uijen for asthma in children. Cochrane Database Syst

Rev.3: CD002173.

130. Tasche MJA, van der Wouden JC, Uijen JHJM et al. (1997). Randomised placebo@controlled trial of inhaled sodium cro@

moglycate in 1—4 year@old children with moderate asthma. Lancet. 350: 1060—1064.

131. Seddon P, Bara A, Ducharme FM, Lasserson TJ. (2006). Oral xanthines as maintenance treatment for asthma in children.

Cochrane Database Syst Rev.1: CD002885.

132. McDonald NJ, Bara AI. (2003). Anticholinergic therapy for chronic asthma in children over two years of age. Cochrane

Database Syst Rev.1: CD003535.

133. Everard ML, Bara A, Kurian M et al. (2005). Anticholinergic drugs for wheeze in children under the age of two years.

Cochrane Database Syst Rev.3: CD001279.

134. Schwarzer G, Bassler D, Mitra A et al. (2004). Ketotifen alone or as additional medication for long@term control of asthma

and wheeze in children. Cochrane Database Syst Rev.1: CD001384.

135. Warner JO. (2001). A double@blind, randomized, placebo@controlled trial of cetirizine in preventing the onset of asthma

in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow@up. J Allergy ClinImmunol.

108: 929—937.

136. Agertoft L, Pedersen S. (1998). Importance of training for correct Turbuhaler use in preschool children. Acta Paediatr.

87: 842—847.

137. O'Callaghan C, Barry PW. (2000). How to choose delivery devices for asthma. Arch Dis Child. 82: 185—187.

138. Castro@Rodriguez JA, Rodrigo GJ. (2004). b@agonists through metered@dose inhaler with valved holding chamber

versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review

with meta@analysis. J Pediatr. 145: 172—177.

139. Iles R, Lister P, Edmunds AT. (1999). Crying significantly reduces absorption of aerosolized drug in infants. Arch Dis Child.

81: 163—165.

140. Janssens HM, Devadason SG, Hop WCJ et al. (1999). Variability of aerosol delivery via spacer devices in young asthmat@

ic children in daily life. Eur Respir J. 13: 787—791.

141. Janssens HM, Heijnen EMEW, de Jong VM et al. (2000). Aerosol delivery from spacers in wheezy infants: a daily life study.

Eur Respir J. 16: 850—856.

142. Ferguson AE, Gibson NA, Aitchison TC, Paton JY. (1995). Measured bronchodilator use in preschool children with asthma.

BMJ. 310: 1161—1164.